News

Under the terms of this licensing agreement, Sirion will have the rights to manufacture, sell and distribute norketotifen for ocular use either alone or in combination with other

This trial was designed to evaluate the safety of NTx-265 in patients suffering acute ischemic stroke and to conduct a preliminary assessment of functional recovery in this patient

The training and protocols will allow Keller clinics, including its joint venture weight clinics and dental sites, to market and sell the Stem Cell Microbank Service. James DeOlden,

Metabolic Research has said that the transition will occur on or before October 18, 2008. The company will retain counsel to guide and facilitate the requisite regulatory processes.

As a result, the company will be extending the dose escalation portion of the study longer than previously communicated. Mary Tagliaferri, Bionovo’s president and chief medical officer, said:

The committee has voted unanimously (12-0) in favor of company’s data being adequate to support the efficacy of the candidate vaccine. The committee voted 11-1 in favor of

The study revealed that premiums, the fixed amount paid by a patient in order to be eligible for reimbursement; deductibles, the amount or percentage of income that makes

As per the study results that were assessed for a 10-year period, under-treatment of depression led to annual costs of E17.9 billion, of which direct costs made up

The company has also announced that under the direction of the Scripps Advanced Clinical Trials center, it is sponsoring a 6000 patient, multi-center trial, called GRAVITAS (Gauging Responsiveness